x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Thrombosis in conversation

Join expert contributors for this podcast series looking at treatment approaches and clinical challenges in venous thromboembolism (VTE), cancer-associated VTE (CAT) and atrial fibrillation (AF). Dr Geoffrey Barnes and guests take on gauging the risk of CAT, and guideline recommendations for VTE and CAT; Professor Gregory Lip and Dr Marco Proietti examine real-world evidence for preventing stroke in people with AF. This podcast is intended for Healthcare Professionals only.

education

All Episodes

21:43

Episode 10: Cancer heterogeneity and CAT

Thrombosis in conversation ·

2024/05/02

Dr Marc Carrier and Dr Barnes discuss the challenges posed by cancer heterogeneity when managing CAT.

en

15:30

Episode 9: Unmet medical needs in AF management

Thrombosis in conversation ·

2024/03/19

Dr Proietti and Professor Lip highlight unmet needs in AF management for stroke prevention and their prevalence among people with AF.

en

14:28

Episode 8: Real-world evidence for managing AF in...

Thrombosis in conversation ·

2024/03/19

Can real-world evidence improve treatment selection and individualised care for AF in stroke prevention? Dr Proietti and Professor Lip discuss.

en

18:40

Episode 7: AF screening and detection technologies in...

Thrombosis in conversation ·

2024/03/19

“Wearable technologies for stroke prevention are an exciting trend in the field” – Dr Proietti and Professor Lip examine the benefits and disadvantages of wearable technologies for AF screening and detection in stroke prevention.

en

15:27

Episode 6: Treatments and guideline recommendations...

Thrombosis in conversation ·

2023/05/04

In this episode, Dr Rajasekhar reviews anticoagulation treatments suitable for CAT (metastatic or non-metastatic cancer), her treatment selection process, and the role of warfarin in this patient group. She outlines her approach to treatment duration for CAT, the appropriateness of using an inferior vena cava (IVC) filter, and her preferred guidelines.

en

16:29

Episode 5: Assessment and guideline recommendations...

Thrombosis in conversation ·

2023/05/04

Dr Anita Rajasekhar (University of Florida) categorises some of the causes and reversible or non-reversible risk factors of VTE for patients without cancer, and the relationship of these to treatment selection. Patient preferences for treatment are important where the cause of VTE is not verified. She also speaks to the location of the clot and VTE risk, and the benefits and limitations of formal assessment of recurrence or bleeding risk. Dr Rajasekhar reviews the guidelines she consults in making

en

19:31

Episode 4: Management of challenging...

Thrombosis in conversation ·

2023/04/13

Episode 4 begins with a discussion on treatment selection for thrombocytopenia. In practice, Dr Deborah Siegal (University of Ottawa) always checks the platelet count in patients at risk of thrombocytopenia, as this affects the suitability of prescribing anticoagulation therapy. The inferior vena cava (IVC) filter in managing protracted thrombocytopenia should be used with care, due to the high complication rate. Dr Siegal outlines strategies for balancing risk of bleeding and VTE recurrence in

en

16:16

Episode 3: Real-world evidence for venous...

Thrombosis in conversation ·

2023/04/13

Drs Barnes and Gregory Piazza (Harvard Medical School) discuss the importance of shared decision-making when determining the most suitable anticoagulation therapy for a patient with VTE. Dr Piazza shares insights on the risk of recurrence with his patients, the importance of reviewing intrinsic and extrinsic risk factors, and how to leverage real-world evidence alongside clinical trial data.

en

20:41

Episode 2: The treatment landscape for...

Thrombosis in conversation ·

2023/04/13

Episode 2 covers the treatment landscape of CAT and how the field has evolved over the past few decades. Dr Khorana discusses the real-world evidence of adherence to injectables versus clinical trial evidence. He stresses the importance of taking a patient’s values and preferences into account when making treatment decisions, and he describes thrombocytopenia, and how to treat objectively identified VTE. The take home message is to educate patients about blood clots: to take the matter seriously

en

20:55

Episode 1: Identifying and stratifying risk of...

Thrombosis in conversation ·

2023/04/13

In episode 1, Dr Alok Khorana (Case Western Reserve University) and Dr Barnes explore why cancer can drive higher risk of VTE, the importance of warning patients of the symptoms of blood clot, and ways to think about risk-stratifying patients who could be at risk of developing CAT. Dr Khorana describes effective approaches to identifying cancer patients at higher risk of VTE, and the implementation of evidence into clinical practice.

en

30 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

Les dents et dodo

BFMTV

一起读书吧！

一起读书吧！

五分钟心理学

柠檬心理

Rock it - dein Raketenstart in den Tag

Hannes kann es